P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF PATIENTS WITH INDOLENT NHL

• P. L. Zinzani,
• S. M. Ansell,
• F. Bosch,
• J. W. Friedberg,
• J. P. Marolleau,
• L. Arcaini,
• R. Garcia-Sanz,
• A. K. Gopal,
• C. Grande,
• R. Merryman,
• A. Pinto,
• S. D. Smith,
• J. C. Villasboas,
• D. Wallace,
• J. Fagerberg,
• J. G. Magalhaes,
• P. Armand

Affiliations

P. L. Zinzani

1 Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy

S. M. Ansell

2 Division of Hematology, Mayo Clinic, Rochester, United States of America

F. Bosch

3 Department of Hematology, Vall d’Hebron Institute of Oncology, Barcelona, Spain

J. W. Friedberg

4 University of Rochester Medical Center, Rochester, United States of America

J. P. Marolleau

5 CHU Amiens, Amiens, France

L. Arcaini

6 Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

R. Garcia-Sanz

7 Hospital Universitario de Salamanca, Salamanca, Spain

A. K. Gopal

8 Division of Medical Oncology, University of Washington, Seattle, United States of America

C. Grande

9 Universidad de Navarra, Madrid and Pamplona, Spain

R. Merryman

10 Dana-Farber Cancer Institute, Boston, United States of America

A. Pinto

11 Istituto Nazionale Tumori “Fondazione G.Pascale”- IRCCS, Naples, Italy

S. D. Smith

12 University of Washington/Fred Hutchinson Cancer Research Center, Seattle

J. C. Villasboas

2 Division of Hematology, Mayo Clinic, Rochester, United States of America

D. Wallace

13 Department of Medicine, University of Rochester, Rochester, United States of America

J. Fagerberg

14 Enterome, Paris, France

J. G. Magalhaes

14 Enterome, Paris, France

P. Armand

10 Dana-Farber Cancer Institute, Boston, United States of America